Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-30
2006-05-30
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S286000, C544S284000
Reexamination Certificate
active
07053099
ABSTRACT:
Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
REFERENCES:
patent: 2833779 (1958-05-01), Fields
patent: 3707475 (1972-12-01), Lombardino
patent: 3772441 (1973-11-01), Lombardino
patent: 3929807 (1975-12-01), Fitzi
patent: 3940486 (1976-02-01), Fitzi
patent: 4058614 (1977-11-01), Baldwin
patent: 4199592 (1980-04-01), Cherkofsky
patent: 4447431 (1984-05-01), Sallmann
patent: 4503065 (1985-03-01), Wilkerson
patent: 4565875 (1986-01-01), Cavender
patent: 4686231 (1987-08-01), Bender et al.
patent: 4822805 (1989-04-01), Takasugi et al.
patent: 4886807 (1989-12-01), Kitamura et al.
patent: 5304560 (1994-04-01), Shimazaki et al.
patent: 5545669 (1996-08-01), Adams et al.
patent: 5559137 (1996-09-01), Adams et al.
patent: 5593991 (1997-01-01), Adams et al.
patent: 5593992 (1997-01-01), Adams et al.
patent: 5656644 (1997-08-01), Adams et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5663334 (1997-09-01), Sheldrake et al.
patent: 5670527 (1997-09-01), Adams et al.
patent: 5686455 (1997-11-01), Adams et al.
patent: 5716955 (1998-02-01), Adams et al.
patent: 5716972 (1998-02-01), Adams et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5756499 (1998-05-01), Adams et al.
patent: 5777097 (1998-07-01), Lee et al.
patent: 5783664 (1998-07-01), Lee et al.
patent: 5811549 (1998-09-01), Adams et al.
patent: 5864036 (1999-01-01), Adams et al.
patent: 5869043 (1999-02-01), McDonnell et al.
patent: 5869660 (1999-02-01), Adams et al.
patent: 5871934 (1999-02-01), Lee et al.
patent: 5916891 (1999-06-01), Adams et al.
patent: 5917043 (1999-06-01), Sisko
patent: 5929076 (1999-07-01), Adams et al.
patent: 5955366 (1999-09-01), Lee et al.
patent: 5969184 (1999-10-01), Adams et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 5998425 (1999-12-01), Adams et al.
patent: 6008235 (1999-12-01), Adams et al.
patent: 6096739 (2000-08-01), Feuerstein
patent: 6150373 (2000-11-01), Harris et al.
patent: 6235760 (2001-05-01), Feuerstein
patent: 6288062 (2001-09-01), Adams et al.
patent: 6335340 (2002-01-01), Gallagher et al.
patent: 6362193 (2002-03-01), Adams et al.
patent: 6528508 (2003-03-01), Salituro et al.
patent: 6875769 (2005-04-01), Chen
patent: 0 477 049 (1992-03-01), None
patent: 0 477 049 (1992-03-01), None
patent: 2 123 830 (1984-02-01), None
patent: WO 91/19497 (1992-06-01), None
patent: WO 92/10190 (1992-06-01), None
patent: WO 92/10498 (1992-06-01), None
patent: WO 92/12154 (1992-07-01), None
patent: WO 93/14081 (1993-07-01), None
patent: WO 93/14082 (1993-07-01), None
patent: WO 94/19350 (1994-09-01), None
patent: WO 95/02591 (1995-01-01), None
patent: WO 95/03297 (1995-02-01), None
patent: WO 95/09847 (1995-04-01), None
patent: WO 95/09851 (1995-04-01), None
patent: WO 95/09852 (1995-04-01), None
patent: WO 95/09853 (1995-04-01), None
patent: WO 95/13067 (1995-05-01), None
patent: WO 95/31451 (1995-11-01), None
patent: WO 98/52558 (1998-11-01), None
patent: WO 98/52937 (1998-11-01), None
patent: WO 98/52940 (1998-11-01), None
patent: WO 98/52941 (1998-11-01), None
patent: WO 98/56377 (1998-12-01), None
patent: WO 98/56788 (1998-12-01), None
patent: WO 98/57966 (1998-12-01), None
patent: WO 99/00357 (1999-01-01), None
patent: WO 99/01130 (1999-01-01), None
patent: WO 99/01131 (1999-01-01), None
patent: WO 99/01136 (1999-01-01), None
patent: WO 99/01449 (1999-01-01), None
patent: WO 99/01452 (1999-01-01), None
patent: WO 99/03837 (1999-01-01), None
patent: WO 99/17776 (1999-04-01), None
patent: WO 99/18942 (1999-04-01), None
patent: WO 99/32110 (1999-07-01), None
patent: WO 99/32121 (1999-07-01), None
patent: WO 99/42592 (1999-08-01), None
patent: WO 99/57101 (1999-11-01), None
patent: WO 99/57253 (1999-11-01), None
patent: WO 99/58128 (1999-11-01), None
patent: WO 99/58502 (1999-11-01), None
patent: WO 99/58523 (1999-11-01), None
patent: WO 99/59959 (1999-11-01), None
patent: WO 99/59960 (1999-11-01), None
patent: WO 99/61426 (1999-12-01), None
patent: WO 99/61437 (1999-12-01), None
patent: WO 99/61440 (1999-12-01), None
patent: WO 99/64400 (1999-12-01), None
patent: WO 00/01688 (2000-01-01), None
patent: WO 00/06563 (2000-02-01), None
patent: WO 00/07980 (2000-02-01), None
patent: WO 00/07991 (2000-02-01), None
patent: WO 00/10563 (2000-03-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/17175 (2000-03-01), None
patent: WO 00/18738 (2000-04-01), None
patent: WO 00/19824 (2000-04-01), None
patent: WO 00/20402 (2000-04-01), None
patent: WO 00/23072 (2000-04-01), None
patent: WO 00/25791 (2000-05-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 00/31063 (2000-06-01), None
patent: WO 00/31065 (2000-06-01), None
patent: WO 00/31072 (2000-06-01), None
patent: WO 00/35911 (2000-06-01), None
patent: WO 00/39116 (2000-07-01), None
patent: WO 00/40243 (2000-07-01), None
patent: WO 00/41698 (2000-07-01), None
patent: WO 00/43384 (2000-07-01), None
patent: WO 00/59541 (2000-10-01), None
patent: WO 00/75131 (2000-12-01), None
patent: WO 01/00229 (2001-01-01), None
patent: WO 01/19322 (2001-03-01), None
patent: WO 01/37837 (2001-05-01), None
patent: WO 01/38312 (2001-05-01), None
patent: WO 01/38313 (2001-05-01), None
patent: WO 01/38314 (2001-05-01), None
patent: WO 01/64679 (2001-09-01), None
patent: WO 02/058695 (2002-01-01), None
patent: WO 02/07772 (2002-08-01), None
patent: WO 02/059083 (2002-08-01), None
patent: WO 02/060869 (2002-08-01), None
Layzer, Degeneraitve Diseases of the Nervous System, Cecil Textbook of Medicine, 20th Edition, vol. 2, pp. 2050-2057, 1996.
Douglas, Jr. Introduction to Viral Diseases, Cecil Textbook of Medicine, 20th Edition, vol. 2, pp. 1739-1747, 1996.
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20th Edition, vol. 2, pp. 1992-1996, 1996.
Gartner et al., PubMed Abstract (Pathol Biol (Paris) 50(2):118-26), Mar. 2002.
Hirasawa et al., Effect of p38 Mitogen-Activated Protein Kinase on the Replication of Encephalomyocarditis Virus, Journal of Virology, vol. 77, No. 10, pp. 5649-5656, May 2003.
Adams et al., “p38 MAP Kinase: Molecular Target for the Inhibition of Pro-inflammatory Cytokines”, Progress in Medicinal Chemistry 38, pp. 2-61, 2001.
Armarego, W. J. Chem. Soc., (JCSOA9) p. 561 (1962).
Badger et al., “Protective Effect of SK&F 86002, a Novel Dual Inhibitor of Arachidonic Acid . . . ”, Circulatory Shock, vol. 27, 1991, pp. 51-61.****.
Badger et al., J. Pharm. Exp. Thera., vol 279 (3), 1996, pp. 1453-1461.
Becker et al., J. Immunol., 147, p. 4307 (1991).
Boehm et al., J. Med. Chem. 39, pp. 3929-3937 (1996).
B. Botta and D. Bertolini, “Cytokine Suppressive Anti-inflammatory Compounds Inhibit Bone Resorption In Vitro”, Bone, vol. 15, No. 5, pp. 533-538 (1994).
Bradlerova et al., Chem. Zvesti, 29 (6), pp. 795-802 (1975).
Cohen et al., “Trends Cell Biology”, 1997, pp. 353-361.
Colotta et al., J. Immunol., 132(2), p. 936 (1984).
Damasio, Cecil Textbook of Medicine, 20thdition, vol. 2, 1996, pp. 1992-1996.
de Silva et al., J. Chem. Soc., 4, pp. 685-690, (1995).
Dinarello et al., Rev.Infect.Disease, 6, p. 51 (1984).
Dinarello, J.Clin.Immun., 5(5), p. 287-297 (1985).
Douglas, Cecil Textbook of Medicine, 20th Edition, vol. 2, 1996, pp. 1739-1747.
Engel & Steglich, Liebigs Ann. Chem., 1916 (1978).
Ferles et al., Collect. Czech. Chem. Commun., 5 (46), pp 1167-1172 (1981).
Fischer et al., Rec.Trav.Chim.Pays.Bas., 84, p. 439 (1965).
Fulmer et al, J. Heterocycl. Chem., 17 (4), pp. 799-800 (1980).
Garigipati, R., Tetrahedron Letters, 31,p. 190 (1989).
Gilbert, Synthesis, pp. 30-32 (1972).
Griswold et al., “Differentiation in vivo of classical non-steroidal antiinflammatory drugs . . . ”, Drugs Exptl. Clin. Res., XIX(6), 1993, pp. 243-248****.
Griswold et al., “Effect of Inhibots of Eicosanoid Metabolism in Murine Collagen-Induced Arthritis”, Arthritis and Rheumatism, vol. 31 No. 11, Nov. 1998, pp. 1406-1412****.
Griswold et al., Pharmacol. Comm., vol 7, 1996, pp. 323-229.
Grunberg et al., Am. J. Respir. Crit. Care Med., v
Adams Jerry L.
Bower Michael J.
Griswold Don Edgar
Hall Ralph
Underwood David C.
Dinner Dara L.
Kinzig Charles M.
Rao Deepak
SmithKline Beecham Corporation
Venetianer Stephen
LandOfFree
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3537447